To sum up, we show that hepatocyte-specific PEX16-absent mice exhibit hepatocyte proliferation, increased liver mass but decreased adipose tissue mass, alteration of fatty acids-cholesterol-bile acid metabolism, and resistance to HFD-induced hepatic steatosis and obesity. This evidence concerns the gene PEX16 and fatty liver disease.